bpc 157 and autoimmune disease BPC-157 BPC-157 & The Gut-Brain Axis:
Description
Research in rats has observed that the peptide may substantially increase the collateral blood vessel growth rate in the setting of ischemia
in Regulatory Toxicology and Pharmacology confirmed the favorable safety profile of this compound across multiple evaluated parameters
Research is ongoing, but the dual approach is intriguing
It is minor but still noticeable
Instead, the fragment appears to promote fat metabolism through GHR-independent pathways
Regular injections provide successful and natural weight loss by reducing excess fat in the body
